Disc Medicine (IRON) Stock: Buy, Sell, or Hold?
IRON - Disc Medicine, Inc. Common Stock
$75.03
-0.97 (-1.28%)
▼
5d:
+32.44%
30d:
+13.53%
90d:
+1.23%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 05, 2026
12d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Oct 19, 2026 at $79.24 · last confirmed Oct 21, 2026
Strength: 6.8/10
Get Alerted When IRON Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: IRON shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: IRON shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: IRON is currently trading at $75.03, which is considered extended relative to its 30-day fair value range of $59.67 to $71.87.
Technical Outlook: Technically, IRON is in a downtrend. Immediate support is located at $55.00, while resistance sits at $81.50.
Market Sentiment: IRON scores 10/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $121.00 (+61.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IRON is in a downtrend. Immediate support is located at $55.00, while resistance sits at $81.50.
Market Sentiment: IRON scores 10/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $121.00 (+61.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$59.67 -
$71.87
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
Protect Your Profits
Holding IRON? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (10/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 61.3% below Wall St target ($121.00)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$59.67 -
$71.87
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$55.00
Resistance Level
$81.50
Current Trend
Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.54
Wall Street Target
$121.00
(+61.3%)
Share & Embed Analysis
Last updated: October 23, 2026 7:07 AM ET
Data refreshes hourly during market hours. Next update: 8:07 AM
Data refreshes hourly during market hours. Next update: 8:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRON showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$139 | 58 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
25 analysts |
$1153 | 52 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 63 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
17 analysts |
$141 | 56 HOLD |
|
CLYM
Climb Bio Inc |
STRONG BUY
15 analysts |
$28 | 63 BUY |
Advanced IRON Option Strategies
Professional options setups generated by AI based on today's IRON price and gamma walls.
